THOMSON SCIENTIFIC REVEALS THE RESULTS OF ITS 2007 LIQUENT REGULATORY AFFAIRS TRENDS SURVEY HIGHLIGHTING SIGNIFICANT GROWTH TRENDS IN eCTD MIGRATION AND SUBMISSIONS OUTSOURCING Monday 23 July 2007 PDF Print Philadelphia, PA, USA – July 23rd , 2007— Liquent, a Thomson business and global leader in providing regulatory software solutions, information products and related services for the life sciences industry, today announced the early findings of its 2007 Liquent Regulatory Affairs Trends Survey. The survey attracted respondents from across the globe representing small, medium and large pharmaceutical companies and provides a unique insight into emerging and future trends in regulatory product management usage and adoption. Now in its fifth year and frequently sourced by pharmaceutical journals and publications across the world, this survey has become the premier benchmark of global regulatory submission trends offering timely insights into how pharmaceutical regulatory professionals use technology today and how they plan to harness technology in the future. 338 Regulatory Affairs professionals working in Life Sciences companies across the globe participated in this survey. The survey concentrates on four key areas; Technology Usage Trends, including both submission publishing software and other desktop software, Document Management System usage, Regulatory Outsourcing trends, and Regulatory trends including use or future use of the electronic Common Technical Document (eCTD). The demographic make-up of the respondent population is similar to previous years with the exception that this year saw a very even split between large pharmaceutical companies (37%) and small to medium companies (33%) participating in the survey, possibly indicating a growing interest amongst the smaller companies in addressing regulatory challenges. Over half of the respondents are from the United States. The majority of the remaining respondents are from Europe, specifically the UK and Germany. Survey highlights include: Technology Usage: - Almost all (90%) of the survey respondents make regulatory submissions; current use of paper and electronic submissions has remained the same since 2006. - Two-thirds (67%) are using submission publishing software, similar to 2006. Over three quarters (77%) of those report that their use of submission software will increase over the next two years - While SAFE and FDA Gateway use are low priority, there is a 7% increase in the use of electronic signatures Regulatory Outsourcing Trends: - Overall, submission outsourcing doubled over last year from 6% to 12%. In European responses, the biggest increases for outsourcing were for printing and regulatory liaisons (for content AND format) - The percentage of respondents who plan to increase the level of printing outsourcing has significantly grown, from 8% in 2006 to 14%. Regulatory Trends: - Three quarters of respondents (76%) plan to migrate to the eCTD. One quarter (26%) of respondents plan to migrate to the eCTD within 3 months, significantly more than in 2006 (4%). - Four in ten (44%) respondents report that their organization plans to adopt an eCTD Viewer within the next two years. This is significantly higher than in 2006, where 32% reported this intention. Jim Nichols is Liquent’s Vice President of Product Strategy and Marketing and pioneered this worldwide initiative. “This year’s survey has once again yielded a tremendous response from regulatory professionals across the life sciences industry and we welcome the significant increase in respondents from small to medium companies who have taken the time to give us their unique views which are invaluable in helping to shape our product direction.” Jim adds, “It is very rewarding to have been ahead of the game in anticipating the likely demand for an eCTD viewer which 4 in 10 respondents to this year’s survey plan to adopt in the next two years. We are perfectly positioned with Liquent InSight® Viewer which directly addresses this need and with the trend for an increase in outsourcing; our Liquent Direct team foresees a significant increase in projects." Full results of the survey, which has attracted extensive interest from publishers and conference organisers, will be available on request. For more information on the survey, its findings and how to secure a copy, please contact Liquent.email@example.com. Editors and writers are invited to liaise with the Survey PR contact, listed at the top of this release to secure copies of the survey results. About Liquent regulatory solutions Liquent regulatory solutions provides software, information products, and related services for the life sciences industry. These solutions and services help ensure clients meet the strict standards of regulatory authorities across the world helping them achieve quality, accuracy, and data integrity to deliver regulatory reports and submissions reliably and on time. In addition to technology and services, the Liquent IDRAC database service provides the most comprehensive intelligence on the drug and biologics regulatory environment in 38 of the largest markets in the world. As a result, 48 of the top 50 global life sciences companies rely on Liquent regulatory solutions to stay current with the latest intelligence and to provide the technology and services to compress the regulatory submissions and approval process, improving speed to market, cost control, and productivity, all of which contribute to ensuring patients’ and physicians’ timely access to new drugs. Over the last decade, more than 5,000 regulatory submissions have been produced using Liquent world-class products and expert services. For more information please visit, www.liquent.com. About The Thomson Corporation The Thomson Corporation (www.thomson.com) is a global leader in providing essential electronic workflow solutions to business and professional customers. With operational headquarters in Stamford, Conn., Thomson provides value-added information, software tools and applications to professionals in the fields of law, tax, accounting, financial services, scientific research and healthcare. The Corporation’s common shares are listed on the New York and Toronto stock exchanges (NYSE: TOC; TSX: TOC). Thomson Scientific is a business of The Thomson Corporation. Its information solutions assist professionals at every stage of research and development—from discovery to analysis to product development and distribution. Thomson Scientific information solutions can be found at scientific.thomson.com. This press release was distributed by ResponseSource Press Release Wire on behalf of Sarum PR in the following categories: Business & Finance, Computing & Telecoms, for more information visit http://pressreleasewire.responsesource.com/about.